AstraZeneca’s launch plan for first-in-class lupus med Saphnelo centers on patient-designed support program
August 19, 2021
AstraZeneca's launch plan for first-in-class lupus med Saphnelo centers on patient-designed support program
bbulik
Mon, 08/02/2021 – 20:29
Read the source article at Pharma News
2021-08-02 21:00:43